Tag Archives: premium
April 2021 Br J Cardiol 2021;28:56–61 doi:10.5837/bjc.2021.018
Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure
Hibba Kurdi, Parin Shah, Simon Barker, Daniel Harris, Benjamin Dicken, Carey Edwards, Geraint Jenkins
(more…)
June 2018 Br J Cardiol 2018;25:73–6 doi:10.5837/bjc.2018.016
Prescribing glucose-lowering drugs for patients with cardiac disease
Miles Fisher, Emma Johns, Gerry McKay
(more…)
March 2018 doi:10.5837/bjc.2018.006
Diagnostic utility of real-time smartphone ECG in the initial investigation of palpitations
Anthony D Dimarco, Eunice N Onwordi, Conrad F Murphy, Emma J Walters, Lorraine Willis, Nicola J Mullan, Nicholas S Peters, Mark A Tanner
(more…)
March 2018 doi:10.5837/bjc.2018.007
Older antidiabetic drugs
Emma Johns, Gerry McKay, Miles Fisher
(more…)
January 2018 doi:10.5837/bjc.2018.001 Online First
Cardio-oncology: a new sub-specialty
Jonathan Bennett, Alexander R Lyon, Chris Plummer, Stuart D Rosen, Kai-Keen Shiu
(more…)
January 2018 doi:10.5837/bjc.2018.003 Online First
What next for troponin? When diagnostic precision muddies the water for the physician
Thomas E Kaier
(more…)
November 2017 Br J Cardiol 2017;24:152–5 doi:10.5837/bjc.2017.030
Glucagon-like peptide-1 (GLP-1) receptor agonists
Emma Johns, Gerry McKay, Miles Fisher
(more…)
October 2017 Br J Cardiol 2017;24:137–41 doi:10.5837/bjc.2017.025 Online First
Heart rate monitors and fitness trackers: friend or foe?
Edward Doris, Iain Matthews, Honey Thomas
(more…)
October 2017 Br J Cardiol 2017;24:(4) doi:10.5837/bjc.2017.026 Online First
How hard do we look for atrial fibrillation?
Ioannis Merinopoulos, Sajid Alam, David Bloore
(more…)
July 2017 Br J Cardiol 2017;24:113–16 doi:http://doi.org/10.5837/bjc.2017.018 Online First
Glitazones (thiazolidinediones)
Emma Johns, Gerry McKay, Miles Fisher
(more…)
For healthcare professionals only
